Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ELI LILLY & Co Director's Dealing 2014

Dec 12, 2014

29745_dirs_2014-12-12_5c19c656-590a-4f77-9f6a-f02d54ac4a66.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: LILLY ELI & CO (LLY)
CIK: 0000059478
Period of Report: 2014-12-10

Reporting Person: Conterno Enrique A (Sr. VP & Pres., Lilly Diabetes)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2014-12-10 Common Stock M 7101 $55.65 Acquired 79837 Direct
2014-12-10 Common Stock F 6046 $72.21 Disposed 73791 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2014-12-10 Employee stock option 2/05 (right to buy) $55.65 M 7101 Disposed 2015-02-10 Common Stock (7101.0) Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 4681 Indirect